Publications:

Treatment-emergent neuroendocrine prostate cancer with a germline BRCA2 mutation: identification of a candidate reversion mutation associated with platinum/PARP-inhibitor resistance.

Cold Spring Harbor Molecular Case Studies

Pandya, Deep D; Shah, Myra M; Kaplan, Fuat F; Martino, Candice C; Levy, Gillian G; Kazanjian, Mia M; Batter, Stephen S; Martignetti, John J; Frank, Richard C RC

Publication Date: 2021-02

Variant appearance in text: KMT2C: 11536del

PubMed Link: 33608381

Variant Present in the following documents:

• Main text
• MCS005801Pan.pdf

View BVdb publication page